Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Decision Tree for Data and Safety Monitoring Plan

Table of Contents

See the main index of Decision Trees or the NIAID Human Subjects Application and Grant Handbook.

Graphical Flowchart

Image map. There is a text-only version available after this image. Click to see the definition in the glossaryClick to see the definition in the glossary

Text Version of Flowchart

Step 1. Are human subjects involved? (even if exempted under 45 CFR Part 46)?

Step 2. Is a Clinical Trial (of any Phase) proposed?

  • If yes:
  • If no:
    • Plan not required.
    • End.

Step 3. Is Data and Safety Monitoring information provided?

  • If yes:
  • If no:
    • Absent. (Negative impact on score, bar to award, or application not reviewed)
    • End.

Step 4.

  • Is the Data and Safety Monitoring plan complete?
    1. Entity responsible for monitoring is described? and
    2. Policies and procedures for adverse event reporting are described? and
    3. Plan is appropriate with respect to risks to participants, complexity of study design, and methods for data analysis? (NIH requires a Data and Safety Monitoring Board for multi-site clinical trials of interventions with potential risk to participants.)
  • Is this plan acceptable?
    • If yes:
      • Acceptable.
      • End.
    • If no:
      • Unacceptable
      • Negative impact on score.
      • End.

Summary of Codes

No specific codes are associated with evaluation as Acceptable or Unacceptable.

See the main index of Decision Trees or the NIAID Human Subjects Application and Grant Handbook.

Last Updated April 19, 2016

Last Reviewed April 19, 2016